First gene-editing therapy recommended by NICE to treat people with beta thalassaemia NHS England said that around 460 patients aged 12 years and over could benefit from the treatment.…
PJ view: Current testing for genetic variants risks undoing years of progress on health inequalities It is crucial that the NHS prioritises health equity as pharmacogenomic testing gains traction in day-to-day UK healthcare.…
Screening for gene variants should be broadened to reduce health inequalities, systematic review concludes Study authors have called for an extension to DPYD genetic testing in the UK, to include variants identified in people with African ancestry.…
DOACs to be analysed as part of genetic biobank scheme Patients who report adverse effects from direct oral anticoagulants to the Yellow Card scheme may be contacted to provide a blood sample, from which data will then be added to a biobank for researchers to analyse.…
Test yourself: the 2023 CPD and Learning quiz Assess your knowledge on topics ranging from infectious diseases, to professional skills, to cardiology, in our end-of-year CPD and learning quiz.…
UK regulator to consider EMA recommendation to avoid topiramate in pregnancy Exclusive: The UK medicines regulator said it would carefully consider recommendations made by the European Medicines Agency, which were published following a review of data showing an increased risk of developmental disorders among children exposed to topiramate before birth.…
Pharmacists asked for views on implementing pharmacogenetics in the NHS Participants in a survey will be presented with a series of hypothetical options related to using pharmacogenetics in the prescribing process, as part of a pilot programme.…
Clopidogrel may be less effective in British South Asian patients, study results suggest The study authors concluded that non-CYP2C19-dependent antiplatelet agents would likely have a "disproportionate benefit" in the British South Asian population.…
Genetic ‘biobank’ version of Yellow Card scheme to be piloted by drugs regulator Genetic data and samples from patients who have experienced adverse side effects to medicines will be stored in the biobank, which will be used to determine whether the reaction was the result of a genetic trait.…
PJ view: a pharmacogenomic revolution is gathering pace There has been rapid progress in the use of pharmacogenomics in patient care over the past 18 months — and it appears to be just the start.…
